384 related articles for article (PubMed ID: 27565572)
1. Global profiling of alternative RNA splicing events provides insights into molecular differences between various types of hepatocellular carcinoma.
Tremblay MP; Armero VE; Allaire A; Boudreault S; Martenon-Brodeur C; Durand M; Lapointe E; Thibault P; Tremblay-Létourneau M; Perreault JP; Scott MS; Bisaillon M
BMC Genomics; 2016 Aug; 17(1):683. PubMed ID: 27565572
[TBL] [Abstract][Full Text] [Related]
2. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of transcriptome profiles in hepatocellular carcinoma.
Jin Y; Lee WY; Toh ST; Tennakoon C; Toh HC; Chow PK; Chung AY; Chong SS; Ooi LL; Sung WK; Lee CG
J Transl Med; 2019 Aug; 17(1):273. PubMed ID: 31429776
[TBL] [Abstract][Full Text] [Related]
4. Differentially expressed genes associated with hepatitis B virus HBx and MHBs protein function in hepatocellular carcinoma.
Kim DG
Methods Mol Biol; 2006; 317():141-55. PubMed ID: 16264227
[TBL] [Abstract][Full Text] [Related]
5. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
[TBL] [Abstract][Full Text] [Related]
6. HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma.
Qiu X; Dong S; Qiao F; Lu S; Song Y; Lao Y; Li Y; Zeng T; Hu J; Zhang L; Zhang L; Fan H
Oncogene; 2013 Jul; 32(27):3296-305. PubMed ID: 23604124
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling of hepatitis B- and hepatitis C-related hepatocellular carcinoma using graphical Gaussian modeling.
Ueda T; Honda M; Horimoto K; Aburatani S; Saito S; Yamashita T; Sakai Y; Nakamura M; Takatori H; Sunagozaka H; Kaneko S
Genomics; 2013 Apr; 101(4):238-48. PubMed ID: 23485556
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features.
Kawai-Kitahata F; Asahina Y; Tanaka S; Kakinuma S; Murakawa M; Nitta S; Watanabe T; Otani S; Taniguchi M; Goto F; Nagata H; Kaneko S; Tasaka-Fujita M; Nishimura-Sakurai Y; Azuma S; Itsui Y; Nakagawa M; Tanabe M; Takano S; Fukasawa M; Sakamoto M; Maekawa S; Enomoto N; Watanabe M
J Gastroenterol; 2016 May; 51(5):473-86. PubMed ID: 26553052
[TBL] [Abstract][Full Text] [Related]
9. Identification of prognostic alternative splicing signatures in hepatitis B or/and C viruses related hepatocellular carcinoma.
Cai Y; Xia J; Wang N; Zhou H
Genomics; 2020 Sep; 112(5):3396-3406. PubMed ID: 32525024
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma.
Kew MC
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():144-52. PubMed ID: 21199526
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin.
Huang JF; Guo YJ; Zhao CX; Yuan SX; Wang Y; Tang GN; Zhou WP; Sun SH
Hepatology; 2013 May; 57(5):1882-92. PubMed ID: 23239537
[TBL] [Abstract][Full Text] [Related]
12. Differential alternative splicing regulation among hepatocellular carcinoma with different risk factors.
Jin YJ; Byun S; Han S; Chamberlin J; Kim D; Kim MJ; Lee Y
BMC Med Genomics; 2019 Dec; 12(Suppl 8):175. PubMed ID: 31856847
[TBL] [Abstract][Full Text] [Related]
13. Transcriptome-wide analysis of alternative RNA splicing events in Epstein-Barr virus-associated gastric carcinomas.
Armero VES; Tremblay MP; Allaire A; Boudreault S; Martenon-Brodeur C; Duval C; Durand M; Lapointe E; Thibault P; Tremblay-Létourneau M; Perreault JP; Scott MS; Bisaillon M
PLoS One; 2017; 12(5):e0176880. PubMed ID: 28493890
[TBL] [Abstract][Full Text] [Related]
14. Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis.
Pang R; Lee TK; Poon RT; Fan ST; Wong KB; Kwong YL; Tse E
Gastroenterology; 2007 Mar; 132(3):1088-103. PubMed ID: 17383430
[TBL] [Abstract][Full Text] [Related]
15. Distinct expression patterns in hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma.
Lee CF; Ling ZQ; Zhao T; Lee KR
World J Gastroenterol; 2008 Oct; 14(39):6072-7. PubMed ID: 18932288
[TBL] [Abstract][Full Text] [Related]
16. Differential expression profiles of sense and antisense transcripts between HCV-associated hepatocellular carcinoma and corresponding non-cancerous liver tissue.
Nagai K; Kohno K; Chiba M; Pak S; Murata S; Fukunaga K; Kobayashi A; Yasue H; Ohkohchi N
Int J Oncol; 2012 Jun; 40(6):1813-20. PubMed ID: 22366890
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus-induced hepatocellular carcinoma.
Xu C; Zhou W; Wang Y; Qiao L
Cancer Lett; 2014 Apr; 345(2):216-22. PubMed ID: 23981576
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of long non-coding RNA expression profiles in hepatitis B virus-related hepatocellular carcinoma.
Gong X; Wei W; Chen L; Xia Z; Yu C
Oncotarget; 2016 Jul; 7(27):42422-42430. PubMed ID: 27285756
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA expression profiles of hepatitis C virus-related dysplasia and hepatocellular carcinoma.
Zhang H; Zhu C; Zhao Y; Li M; Wu L; Yang X; Wan X; Wang A; Zhang MQ; Sang X; Zhao H
Oncotarget; 2015 Dec; 6(41):43770-8. PubMed ID: 26540467
[TBL] [Abstract][Full Text] [Related]
20. P21WAF1/CIP1 messenger RNA expression in hepatitis B, C virus-infected human hepatocellular carcinoma tissues.
Kobayashi S; Matsushita K; Saigo K; Urashima T; Asano T; Hayashi H; Ochiai T
Cancer; 2001 Jun; 91(11):2096-103. PubMed ID: 11391590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]